Somatic mosaicism in the Wiskott-Aldrich syndrome: Molecular and functional characterization of genotypic revertants

Clinical Immunology

Volumn 135, Issue 1, 2010, Pages 72-83

  Davis, Brian R ^a,b   Yan, Qing ^a   Bui, Jacquelin H ^a   Felix, Kumar ^a   Moratto, Daniele ^c   Muul, Linda M ^c   Prokopishyn, Nicole L ^b   Blaese, R Michael ^b   Candotti, Fabio ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Institute for Inherited Disease Research   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Immunodeficiency; Somatic mosaicism; ; Somatic reversion;

Indexed keywords

AMINO ACID; PROLINE; WISKOTT ALDRICH SYNDROME PROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; MOSAICISM; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERTANT; SEQUENCE ANALYSIS; SOMATIC REVERTANT MOSAICISM; T LYMPHOCYTE; WISKOTT ALDRICH SYNDROME;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, WESTERN; CLONE CELLS; GENETIC VARIATION; GENOTYPE; HUMANS; MOSAICISM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 77649234621     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.12.011     Document Type: Article

References (40)

1. Davis B.R., Dicola M.J., Prokopishyn N.L., Rosenberg J.B., Moratto D., Muul L.M., Candotti F., and Michael B.R. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome. Blood 111 (2008) 5064-5067
2. Hirschhorn R. In vivo reversion to normal of inherited mutations in humans. J. Med. Genet. 40 (2003) 721-728
3. Kvittingen E.A., Rootwelt H., Berger R., and Brandtzaeg P. Self-induced correction of the genetic defect in tyrosinemia type I. J. Clin. Invest. 94 (1994) 1657-1661
4. Pasmooij A.M., Pas H.H., Bolling M.C., and Jonkman M.F. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3. J. Clin. Invest. 117 (2007) 1240-1248
5. Pasmooij A.M., Pas H.H., Deviaene F.C., Nijenhuis M., and Jonkman M.F. Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am. J. Hum. Genet. 77 (2005) 727-740
6. Davis B.R., and Candotti F. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol. Res. 44 (2009) 127-131
7. Wada T., Schurman S.H., Otsu M., Garabedian E.K., Ochs H.D., Nelson D.L., and Candotti F. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8697-8702
8. Hirschhorn R., Yang D.R., Puck J.M., Huie M.L., Jiang C.K., and Kurlandsky L.E. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat. Genet. 13 (1996) 290-295
9. Stephan V., Wahn V., Le Deist F., Dirksen U., Broker B., Muller-Fleckenstein I., Horneff G., Schroten H., Fischer A., and de Saint B.G. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl. J. Med. 335 (1996) 1563-1567
10. Wada T., Toma T., Okamoto H., Kasahara Y., Koizumi S., Agematsu K., Kimura H., Shimada A., Hayashi Y., Kato M., and Yachie A. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 106 (2005) 2099-2101
11. Rieux-Laucat F., Hivroz C., Lim A., Mateo V., Pellier I., Selz F., Fischer A., and Le D.F. Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N. Engl. J. Med. 354 (2006) 1913-1921
12. Ariga T., Kondoh T., Yamaguchi K., Yamada M., Sasaki S., Nelson D.L., Ikeda H., Kobayashi K., Moriuchi H., and Sakiyama Y. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J. Immunol. 166 (2001) 5245-5249
13. Ariga T., Yamada M., Sakiyama Y., and Tatsuzawa O. A case of Wiskott-Aldrich syndrome with dual mutations in exon 10 of the WASP gene: an additional de novo one-base insertion, which restores frame shift due to an inherent one-base deletion, detected in the major population of the patient's peripheral blood lymphocytes. Blood 92 (1998) 699-701
14. Wada T., Konno A., Schurman S.H., Garabedian E.K., Anderson S.M., Kirby M., Nelson D.L., and Candotti F. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J. Clin. Invest. 111 (2003) 1389-1397
15. Stewart D.M., Candotti F., and Nelson D.L. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J. Clin. Immunol. 27 (2007) 634-639
16. Zhu Q., Zhang M., Blaese R.M., Derry J.M., Junker A., Francke U., Chen S.H., and Ochs H.D. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 86 (1995) 3797-3804
17. Villa A., Notarangelo L., Macchi P., Mantuano E., Cavagni G., Brugnoni D., Strina D., Patrosso M.C., Ramenghi U., and Sacco M.G. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat. Genet. 9 (1995) 414-417
18. Imai K., Morio T., Zhu Y., Jin Y., Itoh S., Kajiwara M., Yata J., Mizutani S., Ochs H.D., and Nonoyama S. Clinical course of patients with WASP gene mutations. Blood 103 (2004) 456-464
19. Notarangelo L.D., and Ochs H.D. Wiskott-Aldrich syndrome: a model for defective actin reorganization, cell trafficking and synapse formation. Curr. Opin. Immunol. 15 (2003) 585-591
20. Dupre L., Aiuti A., Trifari S., Martino S., Saracco P., Bordignon C., and Roncarolo M.G. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 17 (2002) 157-166
21. Molina I.J., Sancho J., Terhorst C., Rosen F.S., and Remold-O'Donnell E. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151 (1993) 4383-4390
22. Jin Y., Mazza C., Christie J.R., Giliani S., Fiorini M., Mella P., Gandellini F., Stewart D.M., Zhu Q., Nelson D.L., Notarangelo L.D., and Ochs H.D. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 104 (2004) 4010-4019
23. Zhu Q., Watanabe C., Liu T., Hollenbaugh D., Blaese R.M., Kanner S.B., Aruffo A., and Ochs H.D. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 90 (1997) 2680-2689
24. Strom T.S., Gabbard W., Kelly P.F., Cunningham J.M., and Nienhuis A.W. Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther. 10 (2003) 803-809
25. Wada T., Jagadeesh G.J., Nelson D.L., and Candotti F. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. Hum. Gene Ther. 13 (2002) 1039-1046
26. Dupre L., Trifari S., Follenzi A., Marangoni F., Lain de L.T., Bernad A., Martino S., Tsuchiya S., Bordignon C., Naldini L., Aiuti A., and Roncarolo M.G. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol. Ther. 10 (2004) 903-915
27. Imai K., Nonoyama S., and Ochs H.D. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 427-436
28. Araten D.J., Golde D.W., Zhang R.H., Thaler H.T., Gargiulo L., Notaro R., and Luzzatto L. A quantitative measurement of the human somatic mutation rate. Cancer Res. 65 (2005) 8111-8117
29. Araten D.J., Nafa K., Pakdeesuwan K., and Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5209-5214
30. Bielas J.H., and Loeb L.A. Mutator phenotype in cancer: timing and perspectives. Environ. Mol. Mutagen. 45 (2005) 206-213
31. Bigbee W.L., Fuscoe J.C., Grant S.G., Jones I.M., Gorvad A.E., Harrington-Brock K., Strout C.L., Thomas C.B., and Moore M.M. Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies. Mutat. Res. 397 (1998) 119-136
32. Finan P.M., Soames C.J., Wilson L., Nelson D.L., Stewart D.M., Truong O., Hsuan J.J., and Kellie S. Identification of regions of the Wiskott-Aldrich syndrome protein responsible for association with selected Src homology 3 domains. J. Biol. Chem. 271 (1996) 26291-26295
33. Lutskiy M.I., Rosen F.S., and Remold-O'Donnell E. Genotype-proteotype linkage in the Wiskott-Aldrich syndrome. J. Immunol. 175 (2005) 1329-1336
34. Boztug K., Germeshausen M., Avedillo D.I., Gulacsy V., Diestelhorst J., Ballmaier M., Welte K., Marodi L., Chernyshova L., and Klein C. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome. Clin. Genet. 74 (2008) 68-74
35. Lutskiy M.I., Park J.Y., Remold S.K., and Remold-O'Donnell E. Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich syndrome. PLoS ONE 3 (2008) e3444
36. Hayashi Y., Aita T., Toyota H., Husimi Y., Urabe I., and Yomo T. Experimental rugged fitness landscape in protein sequence space. PLoS ONE 1 (2006) e96
37. Yssel H., De Vries J.E., Koken M., Van B.W., and Spits H. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72 (1984) 219-227
38. Yamada M., Ohtsu M., Kobayashi I., Kawamura N., Kobayashi K., Ariga T., Sakiyama Y., Nelson D.L., Tsuruta S., Anakura M., and Ishikawa N. Flow cytometric analysis of Wiskott-Aldrich syndrome (WAS) protein in lymphocytes from WAS patients and their familial carriers. Blood 93 (1999) 756-757
39. Lemahieu V., Gastier J.M., and Francke U. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes. Hum. Mutat. 14 (1999) 54-66
40. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243 (2000) 147-154